Stock CARDIOME PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Cardiome Pharma Corp. Nasdaq

Equities

CA14159U2020

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Cardiome Pharma Corp.
2020 Mark Corrigan Departs as CEO from Correvio Pharma Corp CI
2020 Justin Renz, CFO Departs from Correvio Pharma Corp CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mark Corrigan Departs as CEO from Correvio Pharma Corp
CI
Justin Renz, CFO Departs from Correvio Pharma Corp
CI
Correvio Pharma Corp. Announces Management Changes
CI
Mercury Pharma Group Limited completed the acquisition of Correvio Pharma Corp..
CI
Correvio Pharma : Obtains Final Order for Plan of Arrangement
PR
Correvio Pharma : Announces Results from Annual General and Special Meeting of Securityholders
PR
Transcript : Correvio Pharma Corp. - Shareholder/Analyst Call
Correvio Pharma : Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
PR
Correvio Pharma Corp. Postpones Announcement of Financial Statements for the First Quarter Ended March 31, 2020
CI
Correvio Pharma : Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19
PR
Correvio Pharma : Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
PR
Correvio Pharma : Obtains Interim Order For Plan Of Arrangement
PR
Correvio Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
Correvio Pharma : Reports Full Year 2019 Financial Results
PR
Correvio Pharma Corp. Auditor Raises 'Going Concern' Doubt
CI
CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV
BU
Correvio Pharma : ADVANZ PHARMA to Acquire Correvio
PR
Mercury Pharma Group Limited entered into an arrangement agreement to acquire Correvio Pharma Corp. for $21.3 million.
CI
Correvio Pharma : Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities
PR
Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CORV Stock
  4. Stock
  5. News Cardiome Pharma Corp.